Yahoo! Finance: Biotechnology Industry News: Boston Therapeutics Reports Positive Phase ll Clinical Trial Results of PAZ320 in Patients With Type 2 Diabetes

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

Boston Therapeutics Reports Positive Phase ll Clinical Trial Results of PAZ320 in Patients With Type 2 Diabetes Feb 26th 2013, 12:00 [Marketwire] - Boston Therapeutics, Inc. , a developer of complex carbohydrates to treat diabetes and inflammatory diseases, reports positive results from a Phase ll clinical trial that evaluated the safety and efficacy ...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions